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Resveratrol Stimulates Sphingosine-1-Phosphate
Signaling of Cathelicidin Production
Kyungho Park1,2,3, Peter M. Elias1,2,3, Melanie Hupe1,2,3, Andrew W. Borkowski4,5, Richard L. Gallo4,5,
Kyong-Oh Shin6, Yong-Moon Lee6, Walter M. Holleran1,2,3,7 and Yoshikazu Uchida1,2,3
We recently discovered a regulatory mechanism that stimulates the production of the multifunctional
antimicrobial peptide cathelicidin antimicrobial peptide (CAMP). In response to subtoxic levels of ER stress,
increased sphingosine-1-phosphate (S1P) production activates an NFkB-C/EBPa-dependent pathway that
enhances CAMP production in cultured human keratinocytes. As the multifunctional stilbenoid compound
resveratrol (RESV) increases ceramide (Cer) levels, a precursor of S1P, we hypothesized and assessed whether
RESV could exploit the same pathway to regulate CAMP production. Accordingly, RESV significantly increased Cer
and S1P levels in cultured keratinocytes, paralleled by increased CAMP mRNA/protein expression. Furthermore,
topical RESV also increased murine CAMP mRNA/protein expression in mouse skin. Conversely, blockade
of Cer-sphingosine-S1P metabolic conversion, with specific inhibitors of ceramidase or sphingosine
kinase, attenuated the expected RESV-mediated increase in CAMP expression. The RESV-induced increase in
CAMP expression required both NF-kB and C/EBPa transactivation. Moreover, conditioned media from
keratinocytes treated with RESV significantly suppressed Staphylococcus aureus growth. Finally, topical RESV, if
not coapplied with a specific inhibitor of sphingosine kinase, blocked S. aureus invasion into murine skin. These
results demonstrate that the dietary stilbenoid RESV stimulates S1P signaling of CAMP production through an
NF-kB-C/EBPa-dependent mechanism, leading to enhanced antimicrobial defense against exogenous microbial
pathogens.
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INTRODUCTION
Human epidermis is positioned at the interface with the
environment, protecting underlying tissues from exogenous
microbial pathogens, mechanical damage, and UV irradiation.
These protective mechanisms include the generation of anti-
microbial peptides (AMP) that display activity against a broad
spectrum of different pathogens, including Gram-negative and
Gram-positive bacteria, fungi, and certain viruses (Dunn et al.,
2009; Nijnik and Hancock, 2009; Mendez-Samperio, 2010;
Schroder, 2010). In addition to its antimicrobial function, the
major AMP, cathelicidin antimicrobial peptide (CAMP), is a
multifunctional modulator of cytokine secretion/production,
angiogenesis, and adaptive immune responses (Lai et al.,
2010). Prior studies demonstrated that CAMP expression
increases in epithelial tissues, including in epidermal keratino-
cytes (KCs), after external perturbations, e.g., wounding,
suberythemagenic UVB irradiation, oxidative stress, and
epidermal barrier abrogation (Aberg et al., 2008; Hong
et al., 2008; Kim et al., 2009; Mallbris et al., 2010).
However, if these external perturbations become excessive,
they instead produce cell cycle arrest and apoptosis by
increasing endoplasmic reticulum (ER) stress–induced cera-
mide (Cer) production (Lei et al., 2008). In contrast, subtoxic
perturbations produce lower levels of ER stress, which also
increases Cer transiently. Some of the increased Cer,
generated following subtoxic stress, is metabolized to S1P,
which stimulates CAMP production in epithelial tissues,
including the epidermis, via a (to our knowledge) previously
unidentified NF-kB- and C/EBPa-mediated pathway
(Park et al., 2012). Importantly, this regulatory mechanism
operates independently of the well-established vitamin D
receptor (VDR)–regulated pathway (Gombart et al., 2005),
which instead likely predominates under basal (non-stressed)
conditions.
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Resveratrol (RESV, trans-3,4,5-trihydroxystilbene) belongs
to a class of phytoalexins that are synthesized by a restricted
number of plants, including berries, peanuts, and red
grapes. Notably, the synthesis of RESV in these plants
increases in response to external stressors, i.e., infection
or UV irradiation (Shakibaei et al., 2009). RESV exerts
antioxidant and other anti-inflammatory activities,
as well as regulates cellular proliferation, differentiation,
Sirt modulation, and mitochondria-initiated apoptosis
(Sadruddin and Arora, 2009; Shakibaei et al., 2009).
Pertinent to the current studies, RESV also stimulates Cer
levels in multiple cell types (Dolfini et al., 2007; Signorelli
et al., 2009; Cakir et al., 2011).
We have demonstrated that KCs deploy three metabolic
mechanisms that protect against Cer-induced apoptosis
(Uchida et al., 2010), i.e., Cer-to-glucosylceramide, Cer-to-
sphingomyelin (see also Charruyer et al. (2008)), and
ceramidase-mediated hydrolysis of Cer to sphingosine. We
further showed that subtoxic external perturbations that
induce ER stress and increase cellular Cer production also
stimulate metabolic conversion of sphingosine to S1P, leading
to enhanced CAMP generation (Park et al., 2012). Here, we
show that RESV not only increases Cer production but also
initiates downstream conversion of Cer to S1P, leading to
the stimulation of CAMP production in cultured human KCs.
In addition, we show here that topical RESV stimulates
S1P signaling of CAMP production in vivo (murine skin).
Finally, we demonstrate that pretreatment of KCs with RESV
enhances antimicrobial defense against virulent, exogenous
Staphylococcus aureus. Notably, RESV itself did not induce ER
stress, suggesting that RESV directly stimulates S1P signaling of
CAMP expression. These studies illuminate yet another
important and potentially clinically beneficial biological
activity of RESV, i.e., the ability to enhance epithelial innate
immunity through exploitation of an ER stress–initiated
pathway.
RESULTS
RESV increases cellular levels of S1P in parallel with enhanced
CAMP production
Our prior studies demonstrated that subtoxic levels of ER
stress, induced either by external perturbations, e.g., UVB
irradiation, or by an established pharmacological ER stressor,
e.g., thapsigargin, increase not only the levels of cellular Cer
but also the conversion of Cer to its distal metabolite
sphingosine-1-phosphate (S1P), which then stimulates CAMP
production (Park et al., 2012). Hence, we first assessed here
whether exogenous RESV stimulates the production of cellular
Cer, as well as its downstream metabolites, without inducing
excessive ER stress. Lipid quantification showed a modest, but
significant, increase in Cer, and large increases in both
sphingosine and S1P after treatment of cultured human KCs
with exogenous RESV at concentrationso50mM (Table 1). At
these RESV concentrations, indicators of apoptosis (i.e., cell
viability and poly(ADP-ribose) polymerase (PARP) cleavage)
did not become evident (Figure 1a and b), assuring that these
concentrations of RESV are not toxic. Yet, because still higher
concentrations (4100mM) slightly decreased cell viability
(Figure 1a), we used RESV at concentrations ofo50mM in all
subsequent studies.
We next determined whether exogenous RESV stimulates
CAMP expression in vitro. Quantitative RT–PCR (qRT–PCR)
analysis revealed a significant increase in CAMP mRNA
expression in KCs after 24 hours of exposure to RESV
(Figure 1c and d). Consistent with these alterations in CAMP
mRNA, western immunoblot analysis showed that CAMP
protein levels also increased after RESV treatment
(Figure 1e). Finally, ELISA analysis of culture supernatant
further demonstrated that RESV also enhanced LL-37/CAMP
secretion from KCs (Figure 1f and g). Together, these results
indicate that RESV elevates cellular Cer and S1P levels, in
parallel with an increase in CAMP/LL-37 production and
secretion.
Increased S1P accounts for RESV-mediated enhancement of
CAMP production
Our previous studies demonstrated that S1P, but neither
Cer nor sphingosine, accounts for the ER stress–induced
increases in CAMP production (Park et al., 2012). Hence, we
next investigated whether S1P is the Cer metabolite that
accounts for the RESV-mediated upregulation of CAMP.
Co-incubation of KCs with RESV and N-oleoylethanolamine
(NOE), a potent inhibitor of ceramidase, the hydrolytic
enzyme that generates sphingosine from Cer, significantly
attenuated the expected RESV-induced increase in CAMP
mRNA and protein expression (Figure 1c and e). In contrast,
the addition of NOE alone did not alter CAMP expression.
Together, these results suggest that hydrolysis of Cer by
ceramidase(s) is required for the RESV-induced stimulation of
CAMP expression.
We next determined which distal metabolite of Cer, i.e.,
sphingosine and/or S1P, is (are) responsible for increased
CAMP expression. Inhibition of the conversion of sphingosine
to S1P, using dimethylsphingosine, did not stimulate, but
instead significantly attenuated, the expected RESV-induced
increase in both CAMP mRNA and protein expression
(Figure 1d and e), strongly suggesting that sphingosine is not
the responsible metabolite.
To elucidate whether S1P is the responsible signal, we next
assessed whether RESV stimulates the expression of the
sphingosine kinase (SPHK1 isoform) that accounts for ER
stress–stimulated CAMP expression (Park et al., 2012).
Table 1. Sphingolipid content in human keratinocytes
exposed to endoplasmic reticulum stress
Lipid content (pmol per mg protein±SD)
Treatment Cer Sphingosine S1P
Vehicle 736.3±41.2 19.3±3.2 5.7±0.3
RESV 818.7±41.9a 83.4±3.8a 9.3±0.3a
Abbreviations: Cer, ceramide; RESV, resveratrol; S1P, sphingosine-1-
phosphate.
aPo0.01 (n¼ 3) vs. vehicle.
Mean±SD.
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Accordingly, qRT–PCR analysis revealed an increase in
SPHK1 (1.96±0.09 vs. vehicle control, Po0.01), but not
SPHK2 (1.17±0.06 vs. vehicle control), mRNA expression
after incubation of KCs with RESV, suggesting that RESV
stimulates SPHK1 transcription. In contrast, pretreatment of
KCs with a specific inhibitor of SPHK1, SKI, significantly
attenuated the expected RESV-induced stimulation of both
CAMP production (Figure 1d–f) and secretion (Figure 1g).
Together, these results show that the RESV-induced enhance-
ment of CAMP expression can be attributed to increased
S1P generation, resulting from the stimulation of SPHK1
expression.
RESV increases murine CAMP (mCAMP) expression in murine
epidermis
Prior studies showed that mCAMP, the murine homolog of
CAMP, increases in normal mouse skin following exposure to
subtoxic levels of ER stress (Park et al., 2011), as well as via
S1P-stimulated signaling (Park et al., 2012). Hence, we next
investigated whether mCAMP expression increases in murine
epidermis after topical RESV treatment. Morphological
evidence of toxicity, such as changes in epidermal
thickness or inflammation, did not become evident in
murine skin after treatment with topical RESV (0.5–50 mM
(2.5–250 nmole cm2)) (Figure 2a and b). Yet at these doses,
topical RESV increased both mCAMP mRNA and protein
expression in murine epidermis (Figure 2c and d). Together,
these results validate our in vitro studies by showing that
topical RESV also stimulates mCAMP production in the
epidermis.
RESV-induced stimulation of CAMP expression requires NF-jB
and C/EBPa activation
Our recent studies indicated that NF-kB-mediated C/EBPa
activation is a downstream signal of increased S1P-dependent
CAMP expression (Park et al., 2012). Therefore, we next
assessed changes in NF-kB phosphorylation after RESV
exposure. After incubations with RESV, but not vehicle
alone, additional phosphorylated NF-kB1 (p50) levels
increased, whereas, conversely, blockade of the conversion
of sphingosine to S1P by SKI attenuated the expected increase
in phospho-NF-kB generation (Figure 3a). In addition, the
silencing of SPHK1 using siRNA significantly attenuated RESV-
induced nuclear translocation of NF-kB (Figure 3b). Moreover,
an NF-kB reporter assay revealed a significant increase in NF-
kB transactivity after treatment of KCs with RESV (Figure 3c),
whereas, conversely, inhibition of NF-kB activation, using a
specific inhibitor of NF-kB, BAY11-7082, attenuated the
RESV-induced upregulation of CAMP expression (Figure 3d).
Together, these results indicate that the RESV-induced
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Figure 1. Resveratrol (RESV)-mediated increase in sphingosine-1-phosphate (S1P) is responsible for the stimulation of cathelicidin antimicrobial peptide
(CAMP) expression. HaCaT keratinocytes (KCs) pretreated with or without ceramidase (N-oleoylethanolamine (NOE), 25mM) or SPHK (dimethylsphingosine
(DMS), 2.5mM; SKI, 1mM) inhibitors for 30 minutes were incubated with exogenous RESV (50mM or as indicated) for 24 hours. Cell viability (a) or poly(ADP-ribose)
polymerase (PARP) cleavage as a measure of apoptosis (b). CAMP mRNA expression assessed by quantitative real-time (qRT–PCR) (c and d). CAMP and LL-37
(an active form of CAMP) protein/peptide levels quantified by western immunoblot analysis (e) and ELISA, respectively (f and g). Similar results were
obtained when the experiment was repeated (triplicate) using different cell preparations.
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increase in S1P activates NF-kB, leading to increased CAMP
expression.
To further delineate the mechanism by which RESV
increases CAMP production, we next assessed C/EBPa
activation, a distal step in S1P-induced CAMP upregulation
(Park et al., 2012), by C/EBPa phosphorylation (at both Ser-21
and Thr-222/226). After incubation with RESV, western
immunoblot analysis of C/EBPa demonstrated increased
phosphorylation of both the Ser-21 and Thr-222/226
sites in a KC nuclear fraction (Figure 3e). In contrast, the
addition of SKI selectively decreased the phosphorylation of
Thr-222/226 sites, whereas the Ser-21 phosphorylation site
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Figure 2. Topical resveratrol (RESV) increases murine CAMP (mCAMP) expression in normal murine skin. The flanks of mice were treated with topical
applications of RESV or vehicle (ethanol) alone. Hematoxylin and eosin (H&E) staining (a). Epidermal thickness (b). mCAMP mRNA (c) and protein expression (d).
Similar results were obtained when the experiment was repeated (in duplicate) using different skin preparations. Bar¼ 20mm.
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Figure 3. NF-jB-C/EBPa activation is required for resveratrol (RESV)-induced upregulation of cathelicidin antimicrobial peptide (CAMP) expression. HaCaT
keratinocytes (KCs) were pretreated or transfected with/without a specific inhibitor of SPHK1, SKI (1mM), NF-kB inhibitor (BAY11-7082, 2mM), mitogen-activated
protein (MAP) kinase inhibitors ((U0126, ERK inhibitor), SB (SB201290, p38MAP kinase inhibitor)), or SPHK1-siRNA, followed by incubation with RESV (50mM).
Phosphorylated forms of NF-kB or C/EBPa (either Ser-21 or Thr-222/226) in nuclear fractions were assessed by western immunoblot analysis (a and e). RESV-
induced nuclear translocation of NF-kB was determined by immunohistochemistry (b). NF-kB transactivation was assessed using a luciferase reporter assay (c).
CAMP mRNA (d and f). Similar results were obtained when the experiment was repeated (duplicate) using different cell preparations. Bar¼ 30mm.
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remained unaffected (Figure 3e). These results suggest that
C/EBPa phosphorylation serves as a key downstream trans-
criptional signal for the RESV-stimulated CAMP production
(Figure 5).
Our prior studies showed that p38 mitogen-activated
protein (p38MAP) kinases, which phosphorylate C/EBPa, are
also required for the activation of C/EBPa in response to ER
stress (Park et al., 2011). Accordingly, a p38MAP kinase–
specific inhibitor SB201290 significantly diminished the
expected RESV-induced increase in CAMP mRNA expression
(Figure 3f). In contrast, an inhibitor of ERK (extracellular signal
regulated kinase) (U0126) did not attenuate the RESV-induced
increase in CAMP expression. Together, these results show
that not only C/EBPa phosphorylation but also MAP kinase
are required for the RESV-stimulated increase in CAMP
production.
RESV treatment increases epithelial defense against S. aureus
Finally, we assessed the functional relevance of these mechan-
istic studies by asking whether RESV-induced stimulation of
CAMP production in vitro enhances antimicrobial defense
against a virulent microbial pathogen, i.e., S. aureus
(DmprF strain). Conditioned media, collected from KCs pre-
viously treated with RESV, but neither media alone, nor media
treated with vehicle, suppressed S. aureus growth (Figure 4a).
Pertinently, the potency of RESV was comparable to the levels
of growth inhibition achieved with exogenous synthetic LL-37
(0.05 mM (250 pmole cm 2)), which served as a positive
control in these experiments (Figure 4c).
Finally, we investigated whether murine skin pretreated
with topical RESV blocks the invasion of virulent S. aureus. As
the normal epidermis, with its competent permeability and
antimicrobial barrier, prevents S. aureus invasion, we also
assessed invasions into skin where the barrier had been
compromised by topical oxazolone. Again, topical RESV
significantly increased mCAMP mRNA expression, and this
induction was blocked by coapplications of a specific sphin-
gosine kinase inhibitor SKI (Figure 4b). Gram staining showed
that S. aureus invaded deeply into vehicle and SKI-treated skin
(indicated by arrows in Figure 4c). In contrast, as in our
previous study that showed increased epidermal S1P produc-
tion by topical C2Cer (Park et al., 2012), murine skin that had
been treated with topical RESV resisted S. aureus invasion,
whereas, conversely, S. aureus invasion became evident in
skin cotreated with RESV plus SKI (Figure 4c). Together, these
results indicate that the RESV-stimulated increase in CAMP
production and secretion generates sufficient mCAMP to
interdict highly virulent bacterial pathogens.
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Figure 4. Resveratrol (RESV) enhanced antimicrobial defense through increased cathelicidin antimicrobial peptide (CAMP) production. Growth inhibition
of S. aureus. S. aureus strain were incubated for the indicated times with LL-37 or conditioned medium of HaCaT keratinocytes (KCs) treated with RESV
(50mM) (a). Bacterial invasion studies (ex vivo) (b and c): S. aureus strain were epicutaneously applied to full-thickness pieces of murine skin (n¼ 2) treated with
RESV (50mM (250 nmole cm2)), SKI (1mM), LL-37 RESV (50mM (250 pmole cm 2)), and/or vehicle twice daily for 3 days, followed by incubation for 24 hours
at 37 1C. CAMP mRNA expression in skin was assessed by quantitative real-time (qRT–PCR) (b). Bacterial invasion/growth into murine skin was assessed by
Gram staining (counterstaining with hematoxylin and eosin) (c). Scale bar¼50mm.
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DISCUSSION
The plant stilbenoid RESV has multiple, potentially beneficial
biological activities, not only as an antioxidant owing to its
stilbene structure (Sadruddin and Arora, 2009; Sundaresan
et al., 2011) but also as an (i) activator of SIRT 1 coding of
the NAD-dependent deacetylase sirtuin-1, (ii) inhibitor of
proinflammatory cell adhesion molecule expression, (iii)
stimulator of endolethelial nitric oxide synthase activity, and
(iv) inhibitor of platelet aggregation. Because RESV can
modulate multiple cellular functions, its activity is being
explored in multiple clinical settings, including as an anti-
inflammatory agent, immune modulator, for the treatment of
metabolic syndrome, and to prevent cellular senescence (Baile
et al., 2011; Szkudelski and Szkudelska, 2011; Mercken et al.,
2012). Our studies demonstrate an additional potential clinical
niche for RESV, i.e., as a potent modulator of innate immunity
by stimulation of CAMP production. Although high levels of
ER stress stimulate induced apoptosis, at lower subtoxic levels
Cer is effectively metabolized to S1P, a mechanism that
rescues KCs from cell death (Uchida et al., 2010) while
simultaneously stimulating CAMP production (Park et al.,
2012). As apoptosis was not evident in our present studies, a
similar S1P-mediated rescue mechanism probably accounts
for the stimulation of CAMP production by RESV.
Our prior studies demonstrated that nontoxic levels of
external perturbation, i.e., subtoxic UVB irradiation, as well
as ER stress itself, increase Cer production, followed by the
metabolic conversion of Cer to S1P, leading to the stimulation
of CAMP production (Uchida et al., 2010; Park et al., 2012).
In these studies, we show that RESV exploits this pathway by
directly increasing cellular Cer levels. Pertinently, RESV
increases the catalytic activity but not the mRNA expression
of serine palmitoyl transferase (SPT) (Scarlatti et al., 2003), the
enzyme that catalyzes the initial step in de novo Cer synthesis.
As in the present study, we also found that RESV did not
stimulate mRNA levels for either SPT1 or SPT2 (not shown),
RESV probably stimulates the catalytic activity of SPT.
Increased Cer is then followed by accelerated production of
S1P with SPHK1, but not SPHK2, accounting for the enhanced
metabolic conversion of sphingosine to S1P production by
RESV. RESV, similar to ER stressors, appears to increase S1P
production by stimulation of SPHK1 mRNA expression (Park
et al., 2012). Finally, we further demonstrated that RESV
upregulates CAMP production through the same S1P-NF-
kB-C/EBPa mechanism that we recently characterized in
epithelial cells, including both human and murine KCs (Park
et al., 2012) (Figure 5).
To assess the potential relevance of these findings, we then
showed that the RESV-induced increase in CAMP production
enhances antimicrobial defense both in cultured KCs and in
murine skin exposed to exogenous S. aureus. Yet, stilbene
derivatives, including RESV, display direct antimicrobial
activity against pathogens such as S. aureus, Enterococcus
faecalis, and Pseudomonas aeruginosa (Chan, 2002).
Moreover, the sphingoid base itself is a potent antimicrobial
cationic lipid (Bibel et al., 1992). However, we showed that
inhibition of S1P production attenuates antimicrobial activity
against S. aureus (Figure 4). Hence, increased CAMP by RESV
stimulation of S1P production likely accounts for enhanced
antimicrobial defense in KCs.
As noted above, RESV is a potent activator of sirtuin (Sirt) 1,
a nicotinamide adenine dinucleotide (NADþ )–dependent
deacetylase (a class III histone deacetylase). Although histone
4 acetylation is required for induction of CAMP expression by
the VDR-dependent mechanism (Schauber et al., 2008), Sirt1
does not preferentially catalyze histone 4, suggesting that
RESV unlikely attenuates the VDR pathway. Moreover, Sirt1
deacetylase transcription factors, including forkhead box
O1 (FoxO1), stimulated by RESV cause an increase in the
transcription of target gene(s) by recruitment and formation of
a complex with C/EBPa (Qiao and Shao, 2006). Hence,
although C/EBPa is responsible for downstream stimulation
of S1P-mediated CAMP production, RESV-induced Sirt
activation could additively stimulate CAMP expression.
In summary, we demonstrate a previously unidentified
important biological role of RESV, i.e., RESV enhances
antimicrobial defense through an innate immune element
CAMP via stimulation of S1P-mediated NF-kB-C/EBPa
mechanism in the epidermis.
MATERIALS AND METHODS
Cell culture
Immortalized, nontransformed (HaCaT) KCs derived from human
epidermis (a gift from Dr N Fusenig (Heidelberg, Germany)) were
grown as described previously (Uchida et al., 2002). Culture medium
was switched to serum-free KC growth medium containing 0.07 mM
calcium chloride and growth supplements (Invitrogen, Carlsbad, CA)
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Figure 5. Proposed mechanism of resveratrol (RESV)-mediated stimulation of
cathelicidin antimicrobial peptide (CAMP) production in keratinocytes (KCs).
RESV stimulates cellular ceramide (Cer) production and also increases Cer
metabolic conversion to sphingosine and then SIP by SPHKI (but not SPHK2).
SIP activates NF-kB-phosphorylation, leading to the translocation of phospho-
NF-kB to the nucleus. NF-kB increases p38 mitogen-activated protein
(p38MAP) kinase activation that stimulates C/EBPa by its phosphorylation of
Thr-222/226, rather than Ser-21 sites. C/EBPa binds to the 50-upstream
promoter region of CAMP to upregulate CAMP expression. RESV also
stimulates CAMP/LL-37 secretion from cells, resulting in enhanced
antimicrobial defense in the epidermis.
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1 day before RESV treatment. Cell toxicities, including apoptosis,
were assessed by PARP cleavage, as well as using a viability assay kit
(CCK-8) (Dojindo, Rockville, MD) based on WST-8 formazan dye
(Uchida et al., 2010).
Animal experiments
Female hairless (hr/hr) mice, aged 6–8 weeks old, were purchased
from Charles River laboratories (Wilmington, MA) and maintained in
a temperature- and humidity-controlled room, and given standard
laboratory food and tap water ad libitum (under an Institutional
Animal Care and Use Committee (San Francisco Veterans Adminis-
tration Medical Center)–approved protocol). Mice were treated
topically on the flanks with RESV (0.5–50 mM (2.5–250 nmole cm 2))
or vehicle (ethanol) alone twice daily for 3 days. The change in the
overall morphology was assessed by hematoxylin and eosin staining,
as reported earlier (Park et al., 2011).
Measurement of intercellular levels of sphingolipids
The levels of cellular Cer, sphingosine, and S1P were quantified using
an HPLC system equipped with a fluorometrical detector system
(JASCO, Tokyo, Japan), as described previously (Park et al., 2011).
Sphingolipids are expressed as pmol per mg protein.
qRT–PCR analysis
Quantitative real-time PCR (qRT–PCR) was performed using comple-
mentary DNA prepared from mRNA fractions of cell lysates, as
described previously (Uchida et al., 2010; Park et al., 2011). mRNA
expression was normalized to levels of GAPDH.
Western immunoblot analysis
Western immunoblot analysis was performed as described previously
(Park et al., 2011). The following antibodies were used: Anti-human
or anti-mouse b-actin (Abcam, Cambrige, MA) antibody, anti-
Cathelicidin (CAMP) (LifeSpan Biosciences, Seattle, WA), anti-phospho
NF-kB1 (p50) or anti-NF-kB1 p65 (Santa Cruz Biotechnology, Santa
Cruz, CA), anti-Histone H3, anti-phosphoSer-21 or anti-phosphoThr-
222/226 C/EBPa (Cell Signaling, Boston, MA), or anti-PARP (Sciences,
Franklin Lakes, NJ).
ELISA for LL-37 quantification
LL-37 content of cell lysates and conditioned medium of KCs
incubated with RESV was determined using the ELISA kit (Hycult
Biotech, Plymouth Meeting, PA) in accordance with the manufac-
turer’s instructions.
siRNA transfections and immunohistochemistry
HaCaT KCs were transfected with 20 nM siRNA for SPHK1 (Invitro-
gen), as previously described (Park et al., 2011). Cells were treated
with RESV or vehicle for 60 minutes. NF-kB is distributed using
anti-NF-kB p65 (Santa Cruz Biotechnology) and anti-rabbit IgG
conjugated with fluorescein isothiocyanate (Invitrogen). Cells were
counterstained with the nuclear marker 40,6-diaminido-2-phenyl-
indole (DAPI) (Vector Laboratories, Burlingame, CA).
Dual-luciferase reporter assay for NF-jB transcriptional activity
Transcriptional activities of NF-kB were assessed using Reporter
Kits (SABiosciences, Frederick, MD), as described previously (Park
et al., 2011).
Antimicrobial assay
Antimicrobial activity of conditioned medium collected from KCs
against Staphylococcus aureus (DmprF strain) was assessed as
described previously (Bernard and Gallo, 2010).
S. aureus invasion assay
S. aureus invasion assay was performed as we reported previously
(Park et al., 2012). Briefly, full-thickness pieces of murine skin treated
with RESV, SKI, and/or vehicle (propylene glycol: ethanol, 7:3) were
harvested from hairless mice (24-week-old female, hr/hr, n¼ 5) under
an Institutional Animal Care and Use Committee (San Francisco
Veterans Affairs Medical Center)–approved protocol. Epidermal
permeability barrier was attenuated by topical application of topical
oxazolone (1%) once every other day five times. Mice were treated
with RESV two times daily for the last 3 days, during the last three
oxazolone treatments, before harvesting skin. Skin was placed on a
filter paper, dermis side down, and maintained at the air–medium
interface in KC growth medium (as above). S. aureus (ISP479C) (Siboo
et al., 2001) in PBS or PBS was epicutaneously applied (20ml cm 2),
followed by incubation for 24 hours at 37 1C in 5% CO2. Gram
staining was performed to assess S. aureus invasion (Park et al., 2012).
Statistical analyses
Statistical comparisons were performed using an unpaired Student’s
t-test.
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